论文部分内容阅读
目的探讨普米克令舒联合博利康尼雾化吸入佐治毛细支气管炎的疗效。方法将64例诊断为毛细支气管炎的患者随机分为两组,治疗组除常规治疗外,同时采用普米克令舒联合博利康尼雾化吸入;对照组予常规治疗。结果治疗组总有效率为91.2%,显著高于对照组总有效率63.3%(P<0.05)。结论普米克令舒联合博利康尼雾化吸入治疗毛细支气管炎具有疗程短、见效快、无毒副作用、安全有效等优点,值得临床推广使用。
Objective To investigate the curative effect of pulmicort respules combiblocinib aerosol inhalation on bronchiolitis. Methods Sixty-four patients diagnosed as bronchiolitis were randomly divided into two groups. In addition to conventional treatment, Pulmicort respules were treated with inhalation of pulmicort and inhaled. Patients in the control group were treated routinely. Results The total effective rate in the treatment group was 91.2%, significantly higher than that in the control group (63.3%, P <0.05). Conclusion Pulmicort respules combiblocinib aerosol inhalation for the treatment of bronchiolitis has the advantages of short course of treatment, quick response, no toxic and side effects, safe and effective, and is worthy of clinical promotion.